Ibrexafungerp citrate is a salt form of the antifungal active pharmaceutical ingredient ibrexafungerp, featuring a complex pentacyclic triterpenoid core linked to a triazole-pyridine moiety. It is primarily supplied as a research compound or pharmaceutical raw material for laboratory and manufacturing applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1965291-08-0
Ibrexafungerp
pharmaceutical raw material
5-fluorocytosine
pharmaceutical raw material
Miconazole nitrate
pharmaceutical raw material
Miconazole
pharmaceutical raw material
Micafungin
pharmaceutical raw material
Ramelteon
pharmaceutical raw material
N-(2-((8R)-1,6,7,8-Tetrahydro-2H-indeno(5,4-b)furan-8-yl)ethyl)propanamide
pharmaceutical raw material
Oseltamivir
pharmaceutical raw material
(1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid;2-hydroxypropane-1,2,3-tricarboxylic acid
WKIRTJACGBEXBZ-FQGZCCSZSA-N
C[C@H](C(C)C)[C@]1(CC[C@@]2([C@H]3CC[C@H]4[C@]5(COC[C@]4(C3=CC[C@]2([C@@H]1C(=O)O)C)C[C@H]([C@@H]5OC[C@@](C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O